Coherus Oncology CHRS Peer Comparison

NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT
Peer Comparison

760 Comparable Companies

Industry Group Pharmaceuticals and Biotechnology

Coherus Oncology, Inc. (CHRS) is the 365th largest of 760 Pharmaceuticals and Biotechnology companies by market capitalisation, at 165.28 Mn, behind Oramed Pharmaceuticals at 172.69 Mn. The table below compares all 760 on 7 financial metrics, including companies with a secondary business in the group.

Download Data
# Symbol Company Industry Mkt Cap Price Chg % 1Y P/E P/S Enterprise Value
1 LLY Eli Lilly Pharmaceuticals 1.18 Tn 1,252.10 +3.41% +51.48% 42.04 14.10 1.09 Tn
2 JNJ Johnson & Johnson Pharmaceuticals 610.67 Bn 253.40 -0.21% +32.55% 29.24 6.28 533.62 Bn
3 ABBV AbbVie Pharmaceuticals 500.71 Bn 283.35 -0.06% +25.25% 79.99 7.84 477.86 Bn
4 MRK Merck Pharmaceuticals 358.60 Bn 145.35 -1.36% +72.81% 113.51 5.41 314.55 Bn
5 NVS Novartis Ag Pharmaceuticals 286.95 Bn 150.38 +2.36% +15.70% 18.51 5.33 256.04 Bn
6 AZN Astrazeneca Pharmaceuticals 258.32 Bn 166.66 +2.84% -1.77% 24.52 4.36 229.78 Bn
7 AMGN Amgen Biotechnology 234.64 Bn 434.03 +1.86% +45.98% 26.72 6.13 189.02 Bn
8 GILD Gilead Sciences Biotechnology 195.30 Bn 157.37 +2.49% +33.03% -60.03 6.39 168.69 Bn
9 ABT 2nd Abbott Laboratories Generic Drugs 181.15 Bn 104.69 +1.66% -19.13% 33.60 3.91 152.70 Bn
10 PFE Pfizer Pharmaceuticals 167.74 Bn 29.43 +0.72% +20.66% 38.86 2.64 114.99 Bn
11 VRTX Vertex Pharmaceuticals Biotechnology 128.89 Bn 508.75 +2.06% +24.72% 28.76 10.07 98.70 Bn
12 BMY Bristol Myers Squibb Pharmaceuticals 123.73 Bn 60.57 +2.18% +38.89% 13.13 2.48 73.12 Bn
13 GSK Gsk Pharmaceuticals 105.79 Bn 49.03 +2.40% +11.99% 7.58 1.31 82.68 Bn
14 MRNA Moderna Biotechnology 94.36 Bn 236.50 +4.51% +753.17% -27.27 38.57 65.29 Bn
15 REGN Regeneron Pharmaceuticals Biotechnology 81.86 Bn 796.34 +2.31% +38.15% 18.77 5.23 47.47 Bn
16 COR 2nd Cencora Animal Health 65.13 Bn 341.28 +1.55% +6.78% 25.08 0.20 54.72 Bn
17 TAK Takeda Pharmaceutical Pharmaceuticals 61.93 Bn 19.46 +2.31% +40.40% 108.03 1.33 38.41 Bn
18 ARGX Argenx Se Biotechnology 52.37 Bn 846.27 +3.42% +3.76% 29.28 9.61 34.19 Bn
19 SNY Sanofi Pharmaceuticals 49.13 Bn 40.29 +1.31% -17.71% 10.60 0.92 15.93 Bn
20 TEVA Teva Pharmaceutical Industries Generic Drugs 47.92 Bn 41.12 +0.93% +107.89% 68.45 2.79 35.17 Bn
21 IDXX Idexx Laboratories Animal Health 43.16 Bn 547.18 +3.43% -14.39% 38.85 9.72 43.49 Bn
22 ONC BeOne Medicines Pharmaceuticals 42.28 Bn 374.08 +6.43% +18.32% 62.87 6.73 22.75 Bn
23 RVMD Revolution Medicines Pharmaceuticals 40.55 Bn 189.26 -2.20% +281.88% -21.32 — 27.90 Bn
24 BIIB Biogen Biotechnology 34.77 Bn 235.35 +1.08% +63.82% 41.20 3.43 21.05 Bn
25 ZTS Zoetis Animal Health 32.49 Bn 78.46 +4.17% -44.79% 12.65 3.48 24.93 Bn
Rows

About these peers

Who are Coherus Oncology, Inc.'s peers and competitors?

Coherus Oncology, Inc. (CHRS) is compared with 760 US-listed companies in the Pharmaceuticals and Biotechnology industry group, of which 696 have it as their primary business and 64 run a substantial Pharmaceuticals and Biotechnology business alongside something else.

How are these peers chosen?

Peers are every company that BQ-MICS, our own multi-industry classification system, places in the same industry group as Coherus Oncology, Inc.. Unlike a single-label scheme, BQ-MICS assigns each company a primary industry and any secondary industries it genuinely operates in, and records the reasoning behind every assignment. Tap the info icon beside any ticker to read it.

What does "2nd" next to a ticker mean?

It marks a secondary match: the company operates a real business in this industry group, but it is not its largest. Tick "Primary business only" above the table to compare against pure plays alone.

How often is this peer comparison updated?

Prices, market caps and valuation figures refresh with each session's close. The classification itself is reviewed whenever a company's filings change what it does, such as a new segment, a disposal or an acquisition.

Can I compare these peers on other metrics?

Yes. Use Edit Columns above the table to add any of 1,000+ financial metrics and ratios to the comparison, and Download Data to export it.

Coherus Oncology, Inc. Peers API

Pull Coherus Oncology, Inc.'s industry peers, with any metrics you choose plus the industry median and average, in one call with the Business Quant Peers API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/peers?ticker=CHRS&cols=Revenue%20(Quarter),Net%20Income%20(Quarter)&api_key=YOUR_API_KEY